The purpose of this study is to evaluate the safety and one year disease-free survival of total or subtotal colectomy and proctocolectomy in stage IIIc and stage IV epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC, FTC, PPC).
This trial is to assess the perioperative complications, hospitalization expenses and days, and one year disease-free survival of patients who underwent total or subtotal colectomy as part of the surgical procedures for ovarian cancer, versus partial intestinal resection in the therapy for ovarian cancer.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
Resect all or most parts of the colon: with total or subtotal colectomy as a part of optimal cytoreductive surgery(residual disease \<=0.5cm)
Resect part of the colon or small intestine: with other types of bowel resection as a part of optimal cytoreductive surgery(residual disease \<=0.5cm)
Fudan University Shanghai Zhongshan Hospital
Shanghai, Shanghai Municipality, China
RECRUITINGPostoperative complications
Assessed by Common Terminology Criteria for Adverse Events version 4.0 up to 30 days after surgery
Time frame: up to 30 days after surgery
The rate of 12- month- disease non-progression
Number of patients without progression in 12 months (From date of first chemotherapy until the date of first documented progression, assessed up to 12 months)
Time frame: up to 12 months
Initiation of the first cycle chemotherapy
To compare the date between surgery and initiation of the first cycle chemo
Time frame: up to 12 weeks
Hospitalization expenses
the cost during hospital stay
Time frame: up to 12 weeks
Hospitalization days
length of hospital stay
Time frame: up to 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.